News Releases

News Releases

Synteract Presents Webinar on The Increasing Role of Pharmacometrics in Drug Development

RESEARCH TRIANGLE PARK, NC– September 26, 2019Synteract, an innovative CRO partnering with biotech and pharma companies to bring new medicines to market, will host a complimentary webinar on “The Increasing Role of Pharmacometrics in Drug Development” on Monday, September 30, 2019 at 8 a.m. PST/11a.m. EDT/4p.m. BST/5p.m. CEST. With the cost of a new drug approaching $3B and 12 years, pharmacometrics modeling and simulation holds promise to de-risk and accelerate drug development.

There are several pharmacometrics techniques that can be used at various stages in the drug development pipeline to ascertain the most efficacious doses with increased safety for all patients, including special populations, and that can help to make the approval process more efficient. Synteract speakers, Dr. Felix Boakye-Agyeman and Dr. Rakesh Gollen, will provide an overview of different pharmacometrics tools and techniques, address guidance as to when they can be applied, and discuss key considerations about why these modeling studies may be necessary.

Felix Boakye-Agyeman, M.D., PhD, Director, Pharmacokinetics, has a unique background in medicine, clinical pharmacology, and laboratory medicine, with experience using very sparse and opportunistic sampling to develop popPK models. Previously, as a clinical pharmacologist for Mayo Clinic, Pediatric Trial Network (PTN), and Duke Clinical Research Institute (DCRI), he has collaborated closely with cross-functional trial and project teams, physicians, and external government or industry representatives regarding the pharmacokinetic aspects of each clinical trial or project.

Rakesh Gollen, Ph.D., Director, Pharmacokinetics, is an experienced pharmaceutical scientist with over eight years of industrial experience focused on the development of novel drugs, working in both preclinical and clinical drug development. His expertise crosses multiple therapeutic areas with emphasis on early and late-stage submissions. Dr. Gollen’s experience includes various pharmacokinetics and pharmacometrics approaches including PK/PD, popPK and PBPK.

Biotech and pharma professionals can register for this webinar here: https://xtalks.com/webinars/the-increasing-role-of-pharmacometrics-in-drug-development/ or contact Synteract for additional information.

About Synteract

“Bringing Clinical Trials to Life” represents Synteract’s commitment to engage with drug developers, patients, investigators, and regulatory experts, to bring insights to action and make better therapies a reality. Synteract supports biotech and pharma companies across all phases of drug development to help bring new medicines to market. Synteract has conducted nearly 4,000 studies on six continents and in more than 60 countries. It has contributed to more than 260 product approvals. Synteract offers a notable depth of expertise in oncology, general medicine, dermatology, neuroscience, pediatrics, and rare and orphan diseases. Connect on LinkedIn and Twitter.

# # #
CONTACT:
Beth Walsh
beth@clearpointagency.com
760-230-2424

x

Submit RFI / RFP

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Contact Synteract

Tell us how to stay in touch with you:

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

 

x

Download Resource

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required

x

To complete your download, please choose an option in the Internet Explorer pop-up window at the bottom of this browser.

x

Opt In

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required